{"organizations": [], "uuid": "3151937d8303342cf54b989df2bff18b68d7dced", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-andrew-i-mcdonald-reports-1224-pct/brief-andrew-i-mcdonald-reports-12-24-pct-passive-stake-in-novus-therapeutics-as-of-march-9-idUSFWN1QV0VU", "country": "US", "domain_rank": 408, "title": "BRIEF-Andrew I. Mcdonald Reports 12.24 pct Passive Stake In Novus Therapeutics As Of March 9", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-13T18:17:00.000+02:00", "replies_count": 0, "uuid": "3151937d8303342cf54b989df2bff18b68d7dced"}, "author": "", "url": "https://www.reuters.com/article/brief-andrew-i-mcdonald-reports-1224-pct/brief-andrew-i-mcdonald-reports-12-24-pct-passive-stake-in-novus-therapeutics-as-of-march-9-idUSFWN1QV0VU", "ord_in_thread": 0, "title": "BRIEF-Andrew I. Mcdonald Reports 12.24 pct Passive Stake In Novus Therapeutics As Of March 9", "locations": [], "entities": {"persons": [{"name": "andrew i. mcdonald", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-andrew i. mcdonald reports", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "novus therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 13, 2018 / 4:17 PM / Updated 14 minutes ago BRIEF-Andrew I. Mcdonald Reports 12.24 pct Passive Stake In Novus Therapeutics As Of March 9 Reuters Staff 1 Min Read March 13 (Reuters) - Novus Therapeutics Inc: * ANDREW I. MCDONALD REPORTS 12.24 PERCENT PASSIVE STAKE IN NOVUS THERAPEUTICS INC AS OF MARCH 9, 2018 - SEC FILING‍​ Source text - bit.ly/2FRbXVN Further company coverage:", "external_links": [], "published": "2018-03-13T18:17:00.000+02:00", "crawled": "2018-03-13T18:37:30.006+02:00", "highlightTitle": ""}